CS logo
small CS logo
Centro Universitario Contra El Cancer

Monterrey, Mexico
University in Monterrey
Av. Francisco I. Madero, Mitras Centro, 64640 Monterrey, N.L.

About Centro Universitario Contra El Cancer


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Centro Universitario Contra El Cancer


During the past decade, Centro Universitario Contra El Cancer conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Universitario Contra El Cancer" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Centro Universitario Contra El Cancer


According to Clinical.Site data, the most researched conditions in "Centro Universitario Contra El Cancer" are "Breast Cancer" (2 trials), "Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Centro Universitario Contra El Cancer" in a lesser frequency.

Clinical Trials Intervention Types at Centro Universitario Contra El Cancer


Most popular intervention types in "Centro Universitario Contra El Cancer" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (3 trials), "Paclitaxel" (3 trials), "5-Fluorouracil" (1 trials), "Atezolizumab" (1 trials) and "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Centro Universitario Contra El Cancer


The vast majority of trials in "Centro Universitario Contra El Cancer" are 5 trials for "All" genders.

Clinical Trials Status at Centro Universitario Contra El Cancer


Currently, there are NaN active trials in "Centro Universitario Contra El Cancer". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Centro Universitario Contra El Cancer, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centro Universitario Contra El Cancer, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Departments of Centro Universitario Contra El Cancer


Centro Universitario Contra El Cancer has several departments that took part in Clinical trials: "Hopsital Universitario Dr. Jose E. Gonzalez, Centro Universitario contra el Cancer" - 4 trials